Yan-Peng Chang1, Hui Zhang2, Yan-Ming Xie3, Xian-Bin Zeng2, Jian Hu2, Yan Zhuang4. 1. Institute of Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. cyp2668@163.com 2. Renmin University of China, Beijing 100872, China. 3. Institute of Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. 4. The PLA Navy General Hospital, Beijing 100048, China.
Abstract
OBJECTIVE: Based on real world research the circumstances of the clinical use of usual drugs combined with salvianolate injection are surveyed. METHOD: Descriptive statistics on the use of salvianolate injection in 18 general hospitals in China. RESULT: In 1 605 patients with coronary heart disease (CHD), salvianolate injection was most frequently (51%) combined with clopidogrel and isosorbide dinitrate. In addition this combination showed a higher clinical effectiveness as compared with other drug combinations. CONCLUSION: In the real world, salvianolate injection combined with usual treatment was found to be more effective than other treatment combinations. In addition practice conformed to the clinical treatment of coronary heart disease (CHD) guidelines for drug use. However, liver and kidney function, routine blood tests and the blood's coagulation function require ongoing monitoring.
OBJECTIVE: Based on real world research the circumstances of the clinical use of usual drugs combined with salvianolate injection are surveyed. METHOD: Descriptive statistics on the use of salvianolate injection in 18 general hospitals in China. RESULT: In 1 605 patients with coronary heart disease (CHD), salvianolate injection was most frequently (51%) combined with clopidogrel and isosorbide dinitrate. In addition this combination showed a higher clinical effectiveness as compared with other drug combinations. CONCLUSION: In the real world, salvianolate injection combined with usual treatment was found to be more effective than other treatment combinations. In addition practice conformed to the clinical treatment of coronary heart disease (CHD) guidelines for drug use. However, liver and kidney function, routine blood tests and the blood's coagulation function require ongoing monitoring.